EKSO Q1 2025 Earnings — Ekso Bionics Holdings, Inc. Revenue & Financial Results | Market Cap Arena

EKSOEkso Bionics Holdings, Inc.

$29M

Q1 2025 Earnings

Healthcare Medical - Instruments & Supplies

Income Statement

Revenue

$3M-10.1% YoY

Gross Profit

$2M53.5% margin

Operating Income

-$3M-101.9% margin

Net Income

-$3M-85.7% margin

EPS (Diluted)

$-0.11

QoQ Revenue Growth

-33.7%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$2M

Stock-Based Comp.

$225,000

Balance Sheet

Total Assets

$27M

Total Liabilities

$15M

Stockholders' Equity

$13M

Cash & Equivalents

$8M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$3M	$4M	-10.1%
Gross Profit	$2M	$2M	-7.4%
Operating Income	-$3M	-$3M	-5.7%
Net Income	-$3M	-$3M	+15.7%

Geographic Segments

Americas

$2M27%

UNITED STATES

$2M26%

EMEA

$1M16%

Asia Pacific

$491,0007%

APAC Other

$491,0007%

FRANCE

$422,0006%

ITALY

$407,0006%

Other Country

$255,0004%

Americas Other

$17,0000%